Login to Your Account

Financings Roundup

ChanRx Closes Series A to Advance Atrial Fib Drug

By Marie Powers
Staff Writer

Wednesday, November 23, 2011
ChanRx Corp., launched in 2006 as a spinoff from Cleveland-based pharmaceutical testing company ChanTest Corp., closed a Series A financing with investments from Sante Ventures, of Austin, Texas, and company founder and chairman Arthur "Buzz" Brown.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription